SPHERA FUNDS MANAGEMENT LTD.

Position in FOLD — AMICUS THERAPEUTICS, INC.

CIK 1496201 TEL AVIV, L3

Position in FOLD

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$8,724,831

-$650,457 QoQ

Shares Held

603,377

-8.4% QoQ

Ownership

0.192%

of shares outstanding

% of Portfolio

1.52%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

SPHERA FUNDS MANAGEMENT LTD. holds $325,221,568 across 61 Biotechnology names. FOLD ranks #6 (2.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MLYS	Mineralys Therapeutics, Inc.	1,339,971	$36,299,814
2	BBIO	BridgeBio Pharma, Inc.	245,246	$18,211,967
3	RARE	Ultragenyx Pharmaceutical Inc.	809,333	$16,955,526
4	SNDX	Syndax Pharmaceuticals Inc	724,563	$16,925,791
5	COGT	Cogent Biosciences, Inc.	416,340	$16,024,926
6	FOLD	AMICUS THERAPEUTICS, INC. This page	603,377	$8,724,831
7	APLS	Apellis Pharmaceuticals, Inc.	214,914	$8,645,990
8	BMRN	Biomarin Pharmaceutical Inc	139,900	$7,902,951

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$8,724,831	603,377	-8.4%	Shares	Defined	2026-05-15
2025-12-31	$9,375,288	658,377	-33.6%	Shares	Defined	2026-02-17
2025-09-30	$7,810,198	991,142	+0.0%	Shares	Defined	2025-11-14
2025-06-30	$5,676,814	990,718	+31.6%	Shares	Defined	2025-08-14
2022-06-30	$8,087,617	753,037	+53.3%	Shares	Defined	2022-08-15
2021-09-30	$4,690,568	491,159	+84.8%	Shares	Defined	2021-11-15
2020-12-31	$6,136,236	265,753	-78.6%	Shares	Defined	2021-02-16
2020-09-30	$17,558,926	1,243,550	-23.6%	Shares	Defined	2020-11-12
2020-06-30	$24,558,534	1,628,550	-19.3%	Shares	Defined	2020-08-13
2020-03-31	$18,642,845	2,017,624	—	Shares	Defined	2020-05-14
No filing history on record for this holder in this stock.